Vimarsana
Biggest News Aggregation in the World

Suma Krishnan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Suma Krishnan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Suma Krishnan Today - Breaking & Trending Today

Pier 88 Investment Partners LLC Takes Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Vimarsana News

Pier 88 Investment Partners LLC Takes Position in Krystal Biotech, Inc. (NASDAQ:KRYS)

Pier 88 Investment Partners LLC bought a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 1,170 shares of the company’s stock, valued at approximately $145,000. Other institutional investors have also modified their […]

15,900 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Bought by Fiera Capital Corp - Vimarsana News

15,900 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Bought by Fiera Capital Corp

Fiera Capital Corp purchased a new position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 15,900 shares of the company’s stock, valued at approximately $1,973,000. Several other large investors also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in […]

Source: wkrb13.com
Krystal Biotech (NASDAQ:KRYS) Shares Gap Down to $161.10 - Vimarsana News

Krystal Biotech (NASDAQ:KRYS) Shares Gap Down to $161.10

Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $161.10, but opened at $145.50. Krystal Biotech shares last traded at $156.83, with a volume of 263,735 shares. Wall Street Analysts Forecast Growth KRYS has been the topic of several research […]

Source: wkrb13.com
Krystal Biotech (NASDAQ:KRYS) Rating Reiterated by HC Wainwright - Vimarsana News

Krystal Biotech (NASDAQ:KRYS) Rating Reiterated by HC Wainwright

HC Wainwright reiterated their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a research note published on Monday morning, Benzinga reports. HC Wainwright currently has a $200.00 target price on the stock. A number of other analysts have also weighed in on KRYS. William Blair reiterated an outperform rating on shares […]

Source: wkrb13.com
Krystal Biotech (NASDAQ:KRYS) Given "Buy" Rating at Stifel Nicolaus - Vimarsana News

Krystal Biotech (NASDAQ:KRYS) Given "Buy" Rating at Stifel Nicolaus

Stifel Nicolaus reaffirmed their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $204.00 price target on the stock, up from their prior price target of $178.00. Other research analysts have also recently issued reports about the stock. William Blair […]